15250-m-cuypers

160 Chapter 8 Table 2. Evaluation of DA use in intervention arm DA group (n=30) Mean (SD) DA content (1=completely disagree – 5=completely agree) The DA is based on factual, correct knowledge 4.1 (0.7) The DA is based on actual knowledge 4.1 (0.6) The information in the DA is complete 3.8 (0.7) The DA is steering towards a certain treatment choice 2.4 (0.9) Procedural (1=completely disagree – 5=completely agree) It is clear to me which activities should be executed in what order 4.2 (0.7) The DA offers all information needed to work with 3.8 (0.7) The DA is too complicated for clinicians to work with 2.4 (1.1) The DA fits with standard workflows 3.9 (0.6) I have insufficient trust in the DA 2.2 (0.8) The DA is suitable for all patients with localized Pca 3.6 (1.1) Using the DA saves me time 2.7 (0.8) Patient outcomes (1=completely disagree – 5=completely agree) Effects from using the DA are clearly noticeable 3.2 (0.5) Using the DA is stressful to patients 2.1 (0.6) Activities (1=never – 5=always) Indicating all treatment options, each with their pros and cons 4.7 (0.5) Indicate for which treatments patient is eligible 4.8 (0.5) Indicate where to find relevant information 4.2 (0.9) Stimulate patient to weigh pros and cons 4.7 (0.5) Offer the DA to all eligible patients 4.2 (1.0) Ask for patients’preferences 4.3 (1.1) When needed, further explain the DA 4.2 (1.1) Expectations on DA outcomes by health care providers in the control group did not differ fromexperiences by health care providers in the intervention group (Table 4). Both groups evaluated information goals (comparing treatments, provide insight in pros and cons, actual DA usage) slightly higher than patient outcomes (satisfaction, uncertainty, clarifying preferences), although differences did not reach statistical significance. Time constraints during consultation were not perceived nor expected from DA use. While health care providers in the intervention group felt DA implementation had a good fit with guidelines ( M =4.0, SD =0.3), health care providers in the control group were more neutral about DA use being incorporated in treatment guidelines ( M =3.1, SD =1.0, p <.001; Table 4).